Cytodyn Inc (CYDY)

[3X Charm]

100% failed the CoVID trials, as in did not meet any trial primary or secondary endpoints leading to a direct path to approval via EUA or BLA process.

No one and no entity who’s opinions matter regarding any approvals has accepted the post hoc data mined information as being significant enough to warrant approval.

In fact, the data appears so insignificant that the Brazil trial has only 4 patients enrolled .

Once again Nader must resort to expediency at the expense of scientific significance to try and force a result by reducing the trial size.


The CoVID trials were successful, However in proving once again that Nader is out of his league in the pharma space.

Nader, as always, tried to mislead investors with the tNBC”EUA” in Canada for one patient already receiving LL.
…but we all knew that was a lie.